| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Of Clinical Affairs
1 company
Morosini Deborah is an EVP, Chief Of Clinical Affairs at Prelude Therapeutics Inc. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $15K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Sale+OE | 28,751 | $13.00 | $373,763.00 | -98.5% | -46.2% | -60.9% | |
| Nov 16, 2021 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Sale+OE | 28,751 | $15.88 | $456,531.56 | -95.7% | -39.0% | -51.9% | |
| Apr 29, 2021 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Sale+OE | 3,223 | $40.29 | $129,853.38 | -87.9% | -14.0% | -88.7% | |
| Apr 8, 2021 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Sale+OE | 100 | $40.00 | $4,000.00 | -18.4% | -28.6% | -82.4% | |
| Apr 7, 2021 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Sale+OE | 1,000 | $40.04 | $40,043.00 | -69.3% | -31.2% | -81.8% | |
| Sep 29, 2020 | PRLD Prelude Therapeutics Inc | EVP, Chief Of Clinical Affairs | Buy | 444 | $19.00 | $8,436.00 | New | - | - |